Analysts expect Rigel Pharmaceuticals Inc to report revenue of 84.60 M for Q3 26, against a range of 76.46 M to 92.73 M. The most recent reported quarter, Q2 26, came in at 78.70 M, a 39.0% beat against the 56.61 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 55.31 M | 57.60 M | 53.33 M | 101.69 M | 69.46 M | 69.80 M | 58.82 M | 78.70 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 45.02 M | 57.74 M | 46.03 M | 90.99 M | 67.34 M | 78.67 M | 67.85 M | 61.23 M | 92.73 M | 89.31 M | 86.23 M | 90.53 M | 91.57 M | 105.99 M | 101.83 M | 128.72 M | ||||||||||
| Low Estimate | 41.08 M | 47.30 M | 38.47 M | 80.30 M | 59.36 M | 66.93 M | 60.98 M | 51.99 M | 76.46 M | 76.82 M | 74.37 M | 74.55 M | 75.59 M | 87.96 M | 86.66 M | 120.26 M | ||||||||||
| Consensus Estimate | 43.05 M | 52.52 M | 42.25 M | 85.65 M | 63.35 M | 72.80 M | 64.41 M | 56.61 M | 84.60 M | 83.07 M | 80.30 M | 82.54 M | 83.58 M | 96.98 M | 94.24 M | 124.49 M |
Analysts expect Rigel Pharmaceuticals Inc to report earnings per share of 0.95 for Q3 26, against a range of 0.88 to 1.02. The most recent reported quarter, Q2 26, came in at 0.88, a 780.0% beat against the 0.10 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.70 | 0.80 | 0.63 | 3.28 | 1.46 | 13.54 | 0.44 | 0.88 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.06 | 0.50 | 0.09 | 2.91 | 0.95 | 1.35 | 0.79 | 0.11 | 1.02 | 1.12 | 0.54 | 0.92 | 0.78 | 2.79 | 0.01 | 1.09 | ||||||||||
| Low Estimate | 0.06 | 0.42 | 0.07 | 2.45 | 0.79 | 1.15 | 0.73 | 0.09 | 0.88 | 0.94 | 0.46 | 0.82 | 0.64 | 2.39 | 0.01 | 1.03 | ||||||||||
| Consensus Estimate | 0.06 | 0.46 | 0.08 | 2.68 | 0.87 | 1.25 | 0.76 | 0.10 | 0.95 | 1.03 | 0.50 | 0.87 | 0.71 | 2.59 | 0.01 | 1.06 |
Pull Wall Street consensus for Rigel Pharmaceuticals Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RIGL&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RIGL", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RIGL&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();